Cough Syrup Linked to Child Deaths Banned in Three Indian States

In response to the tragic deaths of at least nine children, three Indian states have enacted a ban on a particular cough syrup, known as Coldrif. The Indian Health Ministry revealed that laboratory tests identified the presence of diethylene glycol (DEG), a highly toxic industrial solvent, in the product manufactured by Sresan Pharma, located in Tamil Nadu.

The chief minister of Madhya Pradesh, where most fatalities occurred, announced the prohibition of Coldrif throughout the state. In addition to this measure, the sale of other products from Sresan Pharma has also been halted. Reports indicate that neighboring states, Tamil Nadu and Kerala, have implemented similar bans on the cough syrup. Furthermore, Telangana has issued a public alert concerning Coldrif.

This incident has reignited concerns about the safety and regulatory oversight of India's pharmaceutical industry. Previously, the World Health Organization (WHO) had linked cough syrups from another Indian manufacturer to the deaths of 70 children in The Gambia in 2022, a claim that the Indian government contested. A year later, the WHO cautioned against two additional cough syrups from India after their use was associated with the deaths of at least 18 children in Uzbekistan. In total, five warnings regarding Indian-made medications have been issued in less than a year due to contamination issues.

India's pharmaceutical sector plays a crucial role globally, supplying approximately 20% of the world's generic medicine market. The country ranks third in the world by volume in pharmaceutical production, with generic drugs typically costing five to six times less than their branded counterparts without significant differences in quality, as noted in a 2011 study published in the Indian Journal of Pharmacology.

The recent events have intensified scrutiny on the regulatory practices governing the production and distribution of pharmaceuticals in India, raising questions about the safety standards that protect consumers both domestically and internationally.